Acenocoumarol

BNF:: 2.8.2
Status:: Grey
Decision Date:: November 2012

Comments

GREY: Treatment option on the recommendation of a consultant/specialist after clarity of dosing and monitoring responsibilities.

Brown Drug Classifications

2: Lack of data on safety compared with standard therapy